Markus Hoffmann

2.7k total citations
78 papers, 1.5k citations indexed

About

Markus Hoffmann is a scholar working on Otorhinolaryngology, Molecular Biology and Oncology. According to data from OpenAlex, Markus Hoffmann has authored 78 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Otorhinolaryngology, 26 papers in Molecular Biology and 26 papers in Oncology. Recurrent topics in Markus Hoffmann's work include Head and Neck Cancer Studies (34 papers), Cervical Cancer and HPV Research (11 papers) and Cancer-related molecular mechanisms research (10 papers). Markus Hoffmann is often cited by papers focused on Head and Neck Cancer Studies (34 papers), Cervical Cancer and HPV Research (11 papers) and Cancer-related molecular mechanisms research (10 papers). Markus Hoffmann collaborates with scholars based in Germany, United States and Switzerland. Markus Hoffmann's co-authors include Tibor Görögh, E. Scherer, Stefan Gottschlich, Silke Tribius, Tomas Kahn, Petra Ambrosch, Elgar Susanne Quabius, Elisabeth Schwarz, Steffen Maune and P. Emmelot and has published in prestigious journals such as Nature, JNCI Journal of the National Cancer Institute and Annals of Oncology.

In The Last Decade

Markus Hoffmann

78 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hoffmann Germany 23 667 465 443 432 334 78 1.5k
Carol G. Shores United States 24 813 1.2× 697 1.5× 929 2.1× 534 1.2× 331 1.0× 65 2.4k
Michael Hier Canada 26 650 1.0× 778 1.7× 404 0.9× 356 0.8× 239 0.7× 89 1.9k
Giovana R. Thomas United States 19 446 0.7× 686 1.5× 437 1.0× 296 0.7× 341 1.0× 40 1.6k
Kevin Fung Canada 22 848 1.3× 459 1.0× 223 0.5× 544 1.3× 151 0.5× 81 1.5k
Joseph Wee Singapore 6 415 0.6× 416 0.9× 365 0.8× 230 0.5× 330 1.0× 7 1.5k
Carmen Gómez United States 14 150 0.2× 368 0.8× 149 0.3× 273 0.6× 81 0.2× 32 897
Jens E. Meyer Germany 18 231 0.3× 146 0.3× 171 0.4× 192 0.4× 74 0.2× 56 811
Sven Koscielny Germany 15 179 0.3× 208 0.4× 239 0.5× 160 0.4× 66 0.2× 64 755
Giuseppe Azzarello Italy 17 127 0.2× 326 0.7× 327 0.7× 192 0.4× 83 0.2× 46 867
Bernd Granzen Netherlands 17 153 0.2× 275 0.6× 282 0.6× 200 0.5× 65 0.2× 35 902

Countries citing papers authored by Markus Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Markus Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hoffmann more than expected).

Fields of papers citing papers by Markus Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hoffmann. The network helps show where Markus Hoffmann may publish in the future.

Co-authorship network of co-authors of Markus Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hoffmann. A scholar is included among the top collaborators of Markus Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hoffmann. Markus Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quabius, Elgar Susanne, et al.. (2025). Therapeutic Impact of Gardasil® in Recurrent Respiratory Papillomatosis: A Retrospective Study on RRP Patients. Viruses. 17(3). 321–321. 1 indexed citations
2.
Meyer, Anne, Markus Hoffmann, Øyvind Skadberg, et al.. (2023). Comparison of three indirect methods for verification and validation of reference intervals at eight medical laboratories: a European multicenter study. Journal of Laboratory Medicine. 47(4). 155–163. 4 indexed citations
3.
Krug, David, Mirko Nitsche, Wolfgang Hoffmann, et al.. (2023). The impact of palliative radiotherapy on health-related quality of life in patients with head and neck cancer – Results of a multicenter prospective cohort study. Clinical and Translational Radiation Oncology. 41. 100633–100633. 1 indexed citations
4.
5.
Hoffmann, Markus, Elgar Susanne Quabius, Alexander Fabian, Martin Laudien, & Petra Ambrosch. (2020). The interaction of smoking habit, SLPI and AnxA2 in HPV associated head and neck and other cancers. Cancer Treatment and Research Communications. 26. 100299–100299. 4 indexed citations
6.
Koch, Evamaria W., et al.. (2018). Cystic masses of the lateral neck – Proposition of an algorithm for increased treatment efficiency. Journal of Cranio-Maxillofacial Surgery. 46(9). 1664–1668. 13 indexed citations
7.
8.
Quabius, Elgar Susanne, Jochen Haag, Anna Sophie Hoffmann, et al.. (2014). Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany. International Journal of Oncology. 46(1). 414–422. 37 indexed citations
9.
Görögh, Tibor, Elgar Susanne Quabius, Patrick Meyer, & Markus Hoffmann. (2014). Characterisation of seven newly established head and neck squamous cell carcinoma cell lines. European Archives of Oto-Rhino-Laryngology. 272(5). 1251–1258. 4 indexed citations
10.
Görögh, Tibor, László Béress, Elgar Susanne Quabius, Petra Ambrosch, & Markus Hoffmann. (2013). Head and neck cancer cells and xenografts are very sensitive to palytoxin: decrease of c-jun n-terminale kinase-3 expression enhances palytoxin toxicity. Molecular Cancer. 12(1). 12–12. 26 indexed citations
11.
Tribius, Silke & Markus Hoffmann. (2013). Human Papilloma Virus Infection in Head and Neck Cancer. Deutsches Ärzteblatt international. 110(11). 184–90, 190e1. 30 indexed citations
12.
Rudolph, Pierre, Axel Heiser, Marie‐Luise Kruse, et al.. (2008). LOXL4 is a selectively expressed candidate diagnostic antigen in head and neck cancer. European Journal of Cancer. 44(9). 1323–1331. 29 indexed citations
13.
Leder, Gerhard, A. Formentini, Markus Hoffmann, & Doris Henne‐Bruns. (2007). Seltene Ursache einer rezidivierenden, nekrotisierenden Pankreatitis. Der Chirurg. 79(3). 252–257. 2 indexed citations
14.
Hoffmann, Markus, et al.. (2007). Häufigkeit und Kosten zusätzlicher stationärer Behandlungen im Jahr nach tagesklinischer oder vollstationärer Alkoholentzugsbehandlung. Psychiatrische Praxis. 34(1). 15–19. 3 indexed citations
15.
Hoffmann, Markus, Stefan Gottschlich, Tibor Görögh, et al.. (2006). HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers.. PubMed. 26(1B). 663–70. 13 indexed citations
16.
Hoffmann, Markus, et al.. (2006). Vermittlung in Entwöhnung nach Alkoholentzugsbehandlung. SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice. 52(5). 297–303. 2 indexed citations
17.
Hoffmann, Markus, et al.. (2005). A Randomised Clinical Trial of In-Patient versus Combined Day Hospital Treatment of Alcoholism: Primary and Secondary Outcome Measures. European Addiction Research. 11(4). 197–203. 7 indexed citations
18.
Fröscher, W., Markus Hoffmann, Andreas Meyer, et al.. (2005). Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy. Epileptic Disorders. 7(3). 237–248. 30 indexed citations
19.
Gottschlich, Stefan, R. Koch, Tibor Görögh, et al.. (2002). Kollagenase-3-mRNA-Expression in Plattenepithelkarzinomen des Oropharynx. HNO. 50(1). 43–47. 3 indexed citations
20.
Duprez, A, et al.. (1989). [In vivo study of human tumor cell proliferation, by histo-immunodetection of 5-iododeoxyuridine incorporated into DNA].. PubMed. 308(12). 313–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol G. Shores Breakdown of academic impact, for papers by Michael Hier Breakdown of academic impact, for papers by Giovana R. Thomas Breakdown of academic impact, for papers by Kevin Fung Breakdown of academic impact, for papers by Joseph Wee Breakdown of academic impact, for papers by Carmen Gómez Breakdown of academic impact, for papers by Jens E. Meyer Breakdown of academic impact, for papers by Sven Koscielny Breakdown of academic impact, for papers by Giuseppe Azzarello Breakdown of academic impact, for papers by Bernd Granzen
Rankless by CCL
2026